To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in Study of QL1101 and Avastin® in Patients With Non-squamous Non-small Cell Lung Cancer
Clinical trial NCT03195569 · UNKNOWN
Trial details
- NCT number
- NCT03195569
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2017-03-01
- Primary completion
- 2018-06-12
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.